BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2845853)

  • 1. Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia.
    Cardiff RD; Aguilar-Cordova E
    Anticancer Res; 1988; 8(5A):925-33. PubMed ID: 2845853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumorigenesis and metastasis in transgenic mice.
    Webster MA; Muller WJ
    Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary gland neoplasia: insights from transgenic mouse models.
    Siegel PM; Hardy WR; Muller WJ
    Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus.
    Peters G; Lee AE; Dickson C
    Nature; 1986 Apr 17-23; 320(6063):628-31. PubMed ID: 3010125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancer.
    Dickson RB; Lippman ME; Slamon D
    Cancer Res; 1990 Jul; 50(14):4446-7. PubMed ID: 2163750
    [No Abstract]   [Full Text] [Related]  

  • 9. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene expression in mammary epithelial cells.
    Groner B
    J Cell Biochem; 1992 Jun; 49(2):128-36. PubMed ID: 1400620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.
    Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A
    Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer.
    van Leeuwen F; Nusse R
    Semin Cancer Biol; 1995 Jun; 6(3):127-33. PubMed ID: 7495980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW; Wagner KU; Hennighausen L
    Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
    Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral-related genes, proto-oncogenes, and breast cancer.
    Callahan R; Weeks MO; Ohuchi N; Schlom J
    Immunol Ser; 1989; 43():623-42. PubMed ID: 2562312
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.